Blincyto Interactions
There are 277 drugs known to interact with Blincyto (blinatumomab), along with 8 disease interactions. Of the total drug interactions, 63 are major, 191 are moderate, and 23 are minor.
- View all 277 medications that may interact with Blincyto
- View Blincyto disease interactions (8)
Most frequently checked interactions
View interaction reports for Blincyto (blinatumomab) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Avastin (bevacizumab)
- Caprelsa (vandetanib)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Cymbalta (duloxetine)
- Entyvio (vedolizumab)
- Esbriet (pirfenidone)
- Hemlibra (emicizumab)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- Kynamro (mipomersen)
- Ofev (nintedanib)
- Pomalyst (pomalidomide)
- Procysbi (cysteamine)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Ravicti (glycerol phenylbutyrate)
- Repatha (evolocumab)
- Revlimid (lenalidomide)
- Sabril (vigabatrin)
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecentriq (atezolizumab)
- Tecfidera (dimethyl fumarate)
- Thalomid (thalidomide)
Blincyto disease interactions
There are 8 disease interactions with Blincyto (blinatumomab) which include:
- vaccination
- leukoencephalopathy
- liver dysfunction
- metabolic acidosis
- neurologic disorders
- neutropenia
- pancreatitis
- renal impairment
Report options
More about Blincyto (blinatumomab)
- Blincyto consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Rasuvo
Rasuvo is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Ponatinib
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Mercaptopurine
Mercaptopurine is used for acute lymphoblastic leukemia, autoimmune hepatitis, crohn's disease ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
